Tibial Tunnel Placement for ACL Reconstruction

April 16, 2015 updated by: Mark Miller, MD, University of Virginia

Tibial Tunnel Placement for ACL Reconstruction: A Prospective, Randomized Clinical Trial

Although extensive research has been carried out on Anterior Cruciate Ligament (ACL) femoral tunnel placement, very little attention has been given to the tibial tunnel. Researchers have suggested that the tibial tunnel be placed in the center of the ACL footprint, which they described as being approximately 43% of the way (anterior-to-posterior) across the proximal tibia at its widest extent. However, others have suggested that a more anterior placement may yield improved biomechanical and clinical results. The center of the ACL footprint and the posterior aspect of the anterior horn of the lateral meniscus does not yield tibial tunnel placement a consistent percentage of the way across the tibial plateau; therefore, guidelines should be based on intraoperative fluoroscopic measurements. However, the question remaining is what percentage of the anterior-to-posterior distance across the tibia is the ideal location for the tibial tunnel in ACL reconstruction. This study will help answer that question.

Patients with a diagnosed rupture of the ACL who are scheduled for surgical reconstruction will be considered for enrollment. Eligible patients will be allocated to one of two groups based on the location of the tibial tunnel (anterior vs. posterior) during the surgical procedure. In addition to a baseline (pre-operative) evaluation, participants will return for follow-up visits at 6, 12, and 24 months post-surgery. Follow up will be completed at 24 months.

The primary objective of this study is to collect subjective and objective measures of knee-related function in patients with an anterior vs. posterior placed tibial tunnel through 24 months postoperative care.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age at time of randomization: 16 - 50 years (skeletally mature)
  • Primary, uncomplicated ACL reconstruction
  • Autograft (STG or BPTB)

Exclusion Criteria:

  • Multiple ligament knee injury (full thickness)
  • Revision ACL reconstruction
  • ACL reconstruction with allograft
  • Meniscectomy > 75%
  • Treatable articular cartilage lesions
  • Diagnosis of tibiofemoral or patellofemoral osteoarthritis (Kellgren Lawrence grade > II)
  • Valgus alignment on long-leg cassette (weight bearing line outside of joint center)
  • Prior surgery in the ankles, knees, or hips
  • Clinical evidence of hip disease
  • Patellofemoral joint instability
  • Significant patellar or tibiofemoral mal-alignment
  • BMI > 35
  • Type 1 Diabetes Mellitus
  • Known connective tissue disorder (e.g. Ehlers-Danlos)
  • Peripheral neuropathy
  • Neurovascular/ circulatory disorder
  • Any form of inflammatory arthritis (e.g. rheumatoid arthritis, gout, pseudogout, lupus, etc.)
  • Significant co-morbid conditions as determined by the investigator (e.g. malignancy, renal, hepatic disease, etc.)
  • Known or suspected psychological disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ACL Reconstruction: Anterior Tunnel
During surgery prior to ACL reconstruction, a line will be measured to indicate 35% of the anterior-to-posterior (front to back) distance of the proximal tibia. The tibial tunnel will be placed anterior (in front) of the 35% line.
ACL reconstruction with anterior tibial tunnel placement in reference to a point measuring 35% of the anterior-posterior distance of the proximal tibia.
Active Comparator: ACL Reconstruction: Posterior Tunnel
During surgery prior to ACL reconstruction, a line will be measured to indicate 35% of the anterior-to-posterior (front to back) distance of the proximal tibia. The tibial tunnel will be placed posterior (in back) of the 35% line.
ACL reconstruction with posterior tibial tunnel placement in reference to a point measuring 35% of the anterior-posterior distance of the proximal tibia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Knee Documentation Committee (IKDC) Subjective Knee Joint Evaluation
Time Frame: 24 months
Subjective knee-specific function
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Injury Outcome and Osteoarthritis Score (KOOS)
Time Frame: 24 months
Subjective knee-specific function
24 months
Marx Activity Rating Scale
Time Frame: 24 months
Subjective rating of physical activity
24 months
Godin Leisure-Time Questionnaire
Time Frame: 24 months
Subjective rating of physical activity
24 months
Tegner Activity Rating
Time Frame: 24 months
Subjective rating of physical activity
24 months
Tampa Scale of Kinesiophobia (TSK)
Time Frame: 24 months
Subjective fear of movement
24 months
Veterans Rand 12-Item Health Survey (VR-12)
Time Frame: 24 months
Subjective global health and quality of life
24 months
Visual Analog Scale (VAS)
Time Frame: 24 months
Subjective pain
24 months
Quadriceps Strength
Time Frame: 24 months
Thigh muscle strength assessment
24 months
Gait Analysis
Time Frame: 24 months
Assessment of 3-dimensional movement patterns while walking
24 months
Knee Arthrometer (KT-1000)
Time Frame: 24 months
Anterior knee laxity
24 months

Other Outcome Measures

Outcome Measure
Time Frame
Knee Joint Range of Motion
Time Frame: 24 months
24 months
Thigh Circumference
Time Frame: 24 months
24 months
X-Ray (AP, lateral views)
Time Frame: 24 months
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Mark D Miller, M.D., University of Virginia
  • Study Director: Joseph M Hart, Ph.D., University of Virginia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Anticipated)

April 1, 2019

Study Completion (Anticipated)

April 1, 2019

Study Registration Dates

First Submitted

February 18, 2015

First Submitted That Met QC Criteria

February 23, 2015

First Posted (Estimate)

March 2, 2015

Study Record Updates

Last Update Posted (Estimate)

April 17, 2015

Last Update Submitted That Met QC Criteria

April 16, 2015

Last Verified

April 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 17922

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complete Tear, Knee, Anterior Cruciate Ligament

Clinical Trials on ACL Reconstruction: Anterior Tunnel

3
Subscribe